Colorado 2024 Regular Session Status: Enacted 2 R cosponsors

SB 24-203 — Prescription Drug Board Consider Rare Disease Advisory Council

Last action — Governor Signed

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed House
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced April 08, 2024. Enacted.

Signed by Governor Jared Polis (Democratic) on June 06, 2024.

Odds of enactment

High chance

Based on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 58% · moderate confidence

  • Enacted

    Current position in the legislative process.

  • 4 sponsors

    4 primary, 0 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (2 R).

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Current law requires the Colorado prescription drug affordability review board (board) to take certain measures in determining whether to conduct an affordability review for an identified prescription drug. The act requires the board, in making such a determination, to consider whether the drug has an approved orphan drug designation for one or more rare diseases and no other indications and, if so, to consider input from consumers and the Colorado rare disease advisory council (council). Current law requires the board, in performing an affordability review, to consider certain information. The act requires the board to consider input from the council. APPROVED by Governor June 6, 2024 EFFECTIVE August 7, 2024(Note: This summary applies to this bill as enacted.)

Bill Text

What changed in the latest version

22 added · 17 removed

Plain-language change summary

The amendment to SB 24-203 adds a new requirement for the Colorado Prescription Drug Affordability Review Board. It now includes the consideration of whether a drug has an approved orphan drug designation for rare diseases when conducting affordability reviews, and mandates the board to seek input from consumers and the Colorado Rare Disease Advisory Council in such cases. This change ensures that the unique circumstances surrounding rare diseases are taken into account during the review process.

→
Previous
Latest
Second Regular Session Seventy-fourth General Assembly STATE OF COLORADO ENGROSSED This Version Includes All Amendments Adopted on Second Reading in the House of Introduction LLS NO.
Second Regular Session Seventy-fourth General Assembly STATE OF COLORADO REENGROSSED This Version Includes All Amendments Adopted in the House of Introduction LLS NO.
24-1151.01 Richard Sweetman x4333 SENATE BILL 24-203 SENATE SPONSORSHIP Ginal and Kirkmeyer, Michaelson Jenet, Smallwood, Will, Zenzinger HOUSE SPONSORSHIP Hartsook and Ortiz, Bird, Bradfield, Brown, deGruy Kennedy, Pugliese, Young Senate Committees House Committees State, Veterans, & Military Affairs A BILL FOR AN ACT C ONCERNING REQUIRING THE COLORADO PRESCRIPTION DRUG AFFORDABILITYREVIEWBOARDTOCONSIDERINPUTFROMTHE C OLORADORAREDISEASEADVISORYCOUNCILUNDERCERTAIN CIRCUMSTANCES .
24-1151.01 Richard Sweetman x4333 SENATE BILL 24-203 SENATE SPONSORSHIP Ginal and Kirkmeyer, Michaelson Jenet, Smallwood, Will, Zenzinger, Buckner, Cutter, Lundeen, Mullica, Priola, Simpson HOUSE SPONSORSHIP Hartsook and Ortiz, Bird, Bradfield, Brown, deGruy Kennedy, Pugliese, Young Senate Committees House Committees State, Veterans, & Military Affairs A BILL FOR AN ACT C ONCERNING REQUIRING THE C OLORADO PRESCRIPTION DRUG AFFORDABILITYREVIEWBOARDTOCONSIDERINPUTFROMTHE C OLORADORAREDISEASEADVISORYCOUNCILUNDERCERTAIN CIRCUMSTANCES .
Bill Summary (Note:
Bill Summary e n (Note:
This summary applies to this bill as introduced and does notreflectanyamendmentsthatmaybesubsequentlyadopted.Ifthisbill passes third reading in the house of introduction, a bill summary that applies to the reengrossed version of this bill will be available at http://leg.colorado.gov.) Current law requires the Colorado prescription drug affordability review board (board) to take certain measures in determining whether to e n conduct an affordability review for an identified prescription drug.
This summary applies to this bill as introduced and does m 2 T n 2 notreflectanyamendmentsthatmaybesubsequentlyadopted.Ifthisbill N g 3 passes third reading in the house of introduction, a bill summary that E d i S e p applies to the reengrossed version of this bill will be available at R A http://leg.colorado.gov.) 3 Current law requires the Colorado prescription drug affordability d review board (board) to take certain measures in determining whether to d conduct an affordability review for an identified prescription drug.
The m 2 T n 2 N g 2 Shading denotes HOUSE amendment.
The e 4 E a 0 A U , N n 2 Shading denotes HOUSE amendment.
E d i Capital letters or bold & italic numbers indicate new material to be added to existing law.
S d r Capital letters or bold & italic numbers indicate new material to be added to existing law.e A Dashes through the words or numbers indicate deletions from existing law.
Dashes through the words or numbers indicate deletions from existing law.
d bill requires the board, in making such a determination, to consider whether the drug has an approved orphan drug designation for one or more rare diseases and no other indications and, if so, to consider input fromconsumersandtheColoradorarediseaseadvisorycouncil(council).
d A bill requires the board, in making such a determination, to consider whether the drug has an approved orphan drug designation for one or more rare diseases and no other indications and, if so, to consider input fromconsumersandtheColoradorarediseaseadvisorycouncil(council).
⬇ Download PDF
View plain text versions (7)

Amendments

1 amendment

Click Show changes on an amendment above to see how it modifies the bill.

Action History

  1. Governor Signed

  2. Signed by the President of the Senate

  3. Signed by the Speaker of the House

  4. Sent to the Governor

  5. House Third Reading Passed - No Amendments

  6. House Second Reading Special Order - Passed - No Amendments

  7. House Second Reading Laid Over Daily - No Amendments

  8. House Committee on Health & Human Services Refer Unamended to House Committee of the Whole

  9. Senate Third Reading Passed - No Amendments

  10. Introduced In House - Assigned to Health & Human Services

  11. Senate Second Reading Special Order - Passed - No Amendments

  12. Senate Committee on State, Veterans, & Military Affairs Refer Unamended - Consent Calendar to Senate Committee of the Whole

  13. Introduced In Senate - Assigned to State, Veterans, & Military Affairs

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

4 sponsors · 0 co-sponsors · 97 not signed on

Sponsors (4)

Co-sponsors (0)

None.

Not signed on (97)

97 members have not signed on to this bill.

Show all 97 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 24-203 do?
Current law requires the Colorado prescription drug affordability review board (board) to take certain measures in determining whether to conduct an affordability review for an identified prescription drug. The act requires the board, in making such a determination, to consider whether the drug has an approved orphan drug designation for one or more rare diseases and no other indications and, if so, to consider input from consumers and the Colorado rare disease advisory council (council). Current law requires the board, in performing an affordability review, to consider certain information. The act requires the board to consider input from the council. APPROVED by Governor June 6, 2024 EFFECTIVE August 7, 2024(Note: This summary applies to this bill as enacted.)
Who sponsors SB 24-203?
SB 24-203 is sponsored by Joann Ginal, Barbara Kirkmeyer (Republican), Anthony Hartsook (Republican), and David Ortiz.
What is the current status of SB 24-203?
This bill has been enacted into law. Introduced April 08, 2024. Enacted.
Where can I track SB 24-203?
Track SB 24-203 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 24-203

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 24-203

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →